Feed
Briefings
Situations
Alpha
Sign in
The GLP-1 blind spot: Why the FDA’s new eye stroke warning matters
rss · The Hill
2026-11-19T17:30:00Z
en
View original
AI brief
It forces the medical community to treat these therapies with clinical gravity instead of casual enthusiasm.
AI Brief
Your highlights
This article is available on the publisher's site.
Read on The Hill
Highlight